EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY-NC 4.0

Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin

Camilo Fuentes Peña iD, María Cecilia Opazo, Luis Méndez iD, Claudia Riedel, Bernard Hauquier, Lionel Marcelis, Frédéric Cotton, Rodrigo Moreno-Reyes iD

European Thyroid Journal · 2024

DOI: 10.1530/etj-24-0142 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift European Thyroid Journal, 2024. Verfasst von Camilo Fuentes Peña und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Hôpital Universitaire de Bruxelles (H.U.B) - Hôpital Erasme, Brussels, Belgium. Hauptthemen laut MEDLINE: Thyroglobulin, Enzyme-Linked Immunosorbent Assay, Dried Blood Spot Testing, Fetal Blood. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Thyroglobulin (Tg) is a biomarker of iodine status. Newborn Tg is a more sensitive marker than neonatal TSH in detecting variations in iodine intake. This study aims to validate an enzyme-linked immunosorbent assay (ELISA) for Tg determination on dried blood spots (DBS) in newborns. This study also sets out to assess the stability of Tg and the influence of newborns’ hematocrit on Tg determination.

Methods

A commercially available ELISA Tg assay was adapted for use on DBS. DBS-Tg in cord blood was measured in 209 newborns delivered from healthy euthyroid pregnant women. Sensitivity, linearity, repeatability, and intermediate fidelity were determined using the appropriate standards and quality control materials.

Results

The limit of detection of the DBS-Tg assay was 2.4 µg/L, and the limit of quantification was 5.8 µg/L. Repeatability and intermediate fidelity were 7.7–8.3% and 11.0–11.2%, respectively. The median cord plasma Tg and DBS-Tg values in newborns were not significantly different, 30.2 (21.3–44.4) µg/L and 31.6 (19.3–48.7) µg/L ( P = 0.48) with the ELISA, respectively, and 76.5 (40.0–101.5) µg/L with the Elecsys assay with an R = 0.88. DBS-Tg concentrations decrease with increasing hematocrit values ( P < 0.05). DBS-Tg values were stable at a concentration of 25 µg/L for 12 months at −20ºC and 4ºC.

Conclusion

This DBS-Tg assay demonstrated good analytical performance over a wide range of Tg concentrations, suggesting it is well suited to detecting variations in Tg concentrations. Studies comparing populations with different prevalence of anemia should consider the effect of hematocrit on DBS-Tg determination. The availability of a DBS-Tg assay for newborns makes it possible to integrate iodine status monitoring with newborn screening for inherited metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThyroglobulinEnzyme-Linked Immunosorbent AssayDried Blood Spot TestingFetal BloodHumansInfant, NewbornFemaleReproducibility of ResultsHematocritNeonatal ScreeningPregnancyMaleIodineSensitivity and SpecificityLimit of DetectionBiomarkers

Stichwörter der Autor:innen

ELISAdried blood spotiodinenewbornthyroglobulin

Substanzen

ThyroglobulinIodineBiomarkers

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Hôpital Universitaire de Bruxelles (H.U.B) - Hôpital Erasme, Brussels, Belgium.
  • Instituto de Ciencias Naturales, Facultad de Medicina Veterinaria y Agronomía, Universidad de Las Américas, Santiago, Providencia, Chile.
  • Millennium Institute on Immunology and Immunotherapy, Facultad de Ciencias de la Vida, Universidad Andrés Bello, Santiago, Chile.
  • Laboratory of Paediatric Research, Université Libre de Bruxelles, Brussels, Belgium.
  • Departament of Clinical Chemistry, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium.
  • École de Santé Publique, Université Libre de Bruxelles, Brussels, Belgium.

ORCID-Profile: Camilo Fuentes Peña, Luis Méndez, Rodrigo Moreno-Reyes

Zitieren

APA

Fuentes Peña, C., Opazo, M. C., Méndez, L., Riedel, C., Hauquier, B., Marcelis, L., Cotton, F., & Moreno-Reyes, R. (2024). Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin. European Thyroid Journal. https://doi.org/10.1530/etj-24-0142

Vancouver

Fuentes Peña C, Opazo MC, Méndez L, Riedel C, Hauquier B, Marcelis L, et al. Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin. European Thyroid Journal. 2024. doi:10.1530/etj-24-0142

BibTeX
@article{FuentesPea2024,
  author = {Fuentes Peña, Camilo and Opazo, María Cecilia and Méndez, Luis and Riedel, Claudia and Hauquier, Bernard and Marcelis, Lionel and Cotton, Frédéric and Moreno-Reyes, Rodrigo},
  title = {Development of an enzyme-linked immunosorbent assay for newborns dried blood spot thyroglobulin},
  journal = {European Thyroid Journal},
  year = {2024},
  doi = {10.1530/etj-24-0142}
}
Kostenlos starten →